Anna Borgenvik

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Mainwaring, Oliver; Weishaupt, Holger; Zhao, Miao; Rosén, Gabriela et al.

Part of Nature Communications, 2023

• DOI for ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
• Download full text (pdf) of ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Borgenvik, Anna; Holmberg, Karl O.; Bolin, Sara; Zhao, Miao et al.

Part of Cancer Research, p. 4586-4603, 2022

• DOI for Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
• Download full text (pdf) of Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

MYC-driven Medulloblastoma: New Targeted Therapies and Mechanisms of Recurrence

Borgenvik, Anna

2021

• Download full text (pdf) of MYC-driven Medulloblastoma: New Targeted Therapies and Mechanisms of Recurrence

Targeting MYCN in Molecularly Defined Malignant Brain Tumors

Borgenvik, Anna; Cancer, Matko; Hutter, Sonja; Swartling, Fredrik J.

Part of Frontiers in Oncology, 2021

• DOI for Targeting MYCN in Molecularly Defined Malignant Brain Tumors
• Download full text (pdf) of Targeting MYCN in Molecularly Defined Malignant Brain Tumors

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma

Bolin, Sara; Borgenvik, Anna; Persson, Camilla U.; Sundström, Anders et al.

Part of Oncogene, p. 2850-2862, 2018

• DOI for Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
• Download full text (pdf) of Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Mainwaring, Oliver; Weishaupt, Holger; Zhao, Miao; Rosén, Gabriela et al.

Part of Nature Communications, 2023

• DOI for ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
• Download full text (pdf) of ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Borgenvik, Anna; Holmberg, Karl O.; Bolin, Sara; Zhao, Miao et al.

Part of Cancer Research, p. 4586-4603, 2022

• DOI for Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
• Download full text (pdf) of Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma

Bolin, Sara; Borgenvik, Anna; Persson, Camilla U.; Sundström, Anders et al.

Part of Oncogene, p. 2850-2862, 2018

• DOI for Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
• Download full text (pdf) of Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma

Targeting MYCN in Molecularly Defined Malignant Brain Tumors

Borgenvik, Anna; Cancer, Matko; Hutter, Sonja; Swartling, Fredrik J.

Part of Frontiers in Oncology, 2021

• DOI for Targeting MYCN in Molecularly Defined Malignant Brain Tumors
• Download full text (pdf) of Targeting MYCN in Molecularly Defined Malignant Brain Tumors

MYC-driven Medulloblastoma: New Targeted Therapies and Mechanisms of Recurrence

Borgenvik, Anna

2021

• Download full text (pdf) of MYC-driven Medulloblastoma: New Targeted Therapies and Mechanisms of Recurrence

CDK2 as a therapeutic target in MYC-driven medulloblastoma

Borgenvik, Anna; Rosén, Gabriela; Holmberg Olausson, Karl; Larsson, Lars-Gunnar et al.